NCT03493490View on ClinicalTrials.gov

Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Pain, PostoperativeAnalgesic Adverse ReactionCruciate Ligament Rupture
Interventions
DRUG

Neodolpasse

Patients will receive two infusions containing 75 mg diclofenac and 30 mg orphenadrine citrate 30 minutes after fixation of the graft replacement and with a time interval of 8 hours.

DRUG

Diclofenac

Patients will receive two infusions containing 75 mg diclofenac 30 minutes after fixation of the graft replacement and with a time interval of 8 hours.

DRUG

Placebo

Patients will receive two physiologic saline infusions 30 minutes after fixation of the graft replacement and with a time interval of 8 hours.

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT03493490 - Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery | Biotech Hunter | Biotech Hunter